"A MISSION OF BETTER HEALTH, LONGEVITY and QUALITY OF LIFE
Strategic Business Development
Communications and Commercial Optimization
Senior Medical Science Liaison
KOL Relationships and Governance.
Biotech-Pharmaceuticals, Devices, Technologies,
Diagnostics, AI, Genetics, Trials and Services.
KOL, HCP and C suite relationships,
identification and development
LifeSciences and Healthcare,
Academic, Corporate and Clinical.
Proven track record helping Life Science Companies,
KOLs, entrepreneurs, clinicians, scientists
& Healthcare Institutions accelerate clinical and
commercial development,
optimize market share and success for patient benefits,
better outcomes and quality of life,
caretaker, provider and stakeholder values.
Exceptional education, success and experience,
relationships, communications and interpersonal skills to
build and generate professional consensus.
Key Opinion Leader insights,
scientific exchange and rapport for
trials, analytics, compliance,
applications, adoption and advocacy.
Advisory Board Development, Honored Society
and Board Relationships with Subject Matter Experts,
Academic & University Medical Centers,
Physicians of Influence and Healthcare Decision Makers.
Analyst, grant review and panel member for the
National Science Foundation, the NSF.
the National Institute of Health, the NIH and
Department of Health & Human Services, the HHS.
Biotech & medical treatments, diagnostics, genomics
bio-pharmaceuticals, devices and therapeutics.
Adept listener, articulate and persuasive,
building professional consensus for better outcomes,
trials, applications, approvals, and advocacy,
greater compliance and adherence, accelerating
the needs, drivers and implementations for success.
In-depth Physician, KOL, HCP & Patient Education.
Pharmaco-economics, HEOR and Vigilance for resource
allocation & adoption. Highly successful with the FDA, FTC,
PhRMA, AHRQ and CMS. Proven track record of success for coverage
and reimbursements by government, insurance, payers and plans.
Honored society, academic and board relationships for strategic CME,
regional and national symposium, publications, communications,
brand and market development, mobile and social media
applications with validation.
Extraordinary resources, knowledge and success
developing and strengthening internal and external
partnerships and alliances with renowned KOL's, academic,
corporate, government and clinical leaders.
GOALS:
Better therapeutics, diagnostics and services
to treat, ameliorate, cure and prevent.
To optimize patient well being, quality of life, caretaker,
provider and stakeholder values
Excellence
in clinical, operational and economic outcomes.
